Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 15, 2018
Source ID
10.3389/fimmu.2018.01349

Entities

People

  • Abdullah Alqarihi
  • Ashraf S. Ibrahim
  • Clint S. Schmidt
  • John E. Edwards
  • John P. Hennessey Jr.
  • Michael R. Yeaman
  • Priya Uppuluri
  • Scott G. Filler
  • Shakti Singh

Organizations

  • American Heart Association
  • National Institute of Allergy and Infectious Diseases
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech